@article{20510,
  author = {Jiang L. and Hopewell J. and Collins R. and Baigent C. and Landray M. and Pedersen T. and Armitage J. and Chen Y. and Chen Z. and Hill M. and Haynes R. and Haynes R. and HPS2-THRIVE Collaborative Group and J. Li and F. Chen and S. Parish},
  title = {HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment},
  year = {2013},
  journal = {European Heart Journal},
  volume = {34},
  edition = {26 February 2013},
  number = {17},
  pages = {1279-91},
  language = {eng},
}